MICI Q2 2024
April 30, 2024
Share this article:
2024 MICI Q2 Shows More Confidence in Growth Than Q4 2023
The Medical Imaging Confidence Index (MICI) Q2 2024 results indicate more confidence in growth, but less confidence in reimbursement and costs.
Co-developed with AHRA, MICI benchmarks the business climate in imaging with quarterly findings about current and future trends for medical imaging reimbursement, revenue, cost, purchasing, and growth. If you’re ready to use detailed MICI report findings to improve your imaging forecasting process, please contact us to learn more.
Q2 2026 IVD market analysis across Core Lab, Molecular Dx, and Microbiology/Specialty Dx, with a 12-company competitive scorecard, management VOC quotes, and a Q3 2026 outlook from Ensolve Research.
New imagePRO QuickPoll findings reveal how recent Medicare ASC reimbursement changes are affecting imaging procedure volumes, health systems, and key modalities.
Learn how to conduct a healthcare market study, from defining research objectives and audiences to selecting methodologies and turning insights into strategy.